ATRA — Atara Biotherapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $80.68m
- $64.52m
- $8.57m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 259 | 501 | 371 | 243 | 51.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 1.25 | 0.986 | 40.2 | 34.1 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 273 | 523 | 385 | 295 | 102 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 68.2 | 62.8 | 79.9 | 74.3 | 58.8 |
Other Long Term Assets | |||||
Total Assets | 343 | 588 | 468 | 376 | 166 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 36.7 | 82.9 | 106 | 78.9 | 142 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 52.2 | 126 | 189 | 250 | 265 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 291 | 462 | 280 | 127 | -99.2 |
Total Liabilities & Shareholders' Equity | 343 | 588 | 468 | 376 | 166 |
Total Common Shares Outstanding |